Chronic-phase chronic myeloid leukemia: Not always a reassuring diagnosis.

about

Experience with dasatinib and nilotinib use in pregnancy.

P2860

Q47238424-82E4D84A-3CFD-475C-B568-0C6ECC027703

P2860

Chronic-phase chronic myeloid leukemia: Not always a reassuring diagnosis.

Item

http://www.wikidata.org/entity/Q35925580

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Chronic-phase chronic myeloid leukemia: Not always a reassuring diagnosis.

@ast

Chronic-phase chronic myeloid leukemia: Not always a reassuring diagnosis.

@en

type

Item

label

Chronic-phase chronic myeloid leukemia: Not always a reassuring diagnosis.

@ast

Chronic-phase chronic myeloid leukemia: Not always a reassuring diagnosis.

@en

prefLabel

Chronic-phase chronic myeloid leukemia: Not always a reassuring diagnosis.

@ast

Chronic-phase chronic myeloid leukemia: Not always a reassuring diagnosis.

@en

P1476

Chronic-phase chronic myeloid leukemia: Not always a reassuring diagnosis

@en

P2093

Chiara Elena

http://www.w3.org/2001/XMLSchema#string

Ester M Orlandi

http://www.w3.org/2001/XMLSchema#string

P2860

A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias

Tyrosine kinase inhibitors and pregnancy.

Early response with dasatinib or imatinib in chronic myeloid leukemia: 3-year follow-up from a randomized phase 3 trial (DASISION).

[Guidelines for the management of nilotinib (Tasigna)-induced side effects in chronic myelogenous leukemia: recommendations of French Intergroup of CML (Fi-LMC group)].

Early molecular response predicts outcomes in patients with chronic myeloid leukemia in chronic phase treated with frontline nilotinib or imatinib

European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013.

The effects of imatinib on pregnancy outcome

Two successful pregnancies in a woman with chronic myeloid leukemia exposed to nilotinib during the first trimester of her second pregnancy: case study.

Implications of BCR-ABL1 kinase domain-mediated resistance in chronic myeloid leukemia.

P304

45-46

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1016/J.LRR.2015.05.003

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Silvia Zibellini

P577

2015-07-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281058253

http://www.w3.org/2001/XMLSchema#string

P698

26266095

http://www.w3.org/2001/XMLSchema#string

P921

chronic myeloid leukemia

P932

4528049

http://www.w3.org/2001/XMLSchema#string

Chronic-phase chronic myeloid leukemia: Not always a reassuring diagnosis.

about

P2860

P2860

Chronic-phase chronic myeloid leukemia: Not always a reassuring diagnosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P932